
Menopause: Assessment and Hormonal Treatment
(17 May 2022, on-demand release) MEMBER EXCLUSIVE: Objectives include to: identify women in menopause transition who are best candidates for HT; improve benefits and decrease risks through HT individualization; and reinforce that Testosterone is not part of menopause replacement therapy and should not be automatically prescribed. (1 AMA PRA Category 1 Credit, 1 ABIM-MOC Point, 1 Participation Credit)
Learn More